一项随机对照试验:评估改变睡眠时间能否改善糖尿病前期和2型糖尿病患者的糖代谢
该随机对照试验计划纳入60例存在超过1小时社交时差的糖尿病前期或2型糖尿病患者,干预组接受为期3周的晨间强光治疗(5000 lx,30分钟)、晚间强光减弱及睡眠提前指导,对照组维持常规睡眠习惯。主要结局为12周时糖化血红蛋白(HbA1c)的组间比较,采用意向性分析。
要点
- 纳入标准为糖尿病前期或2型糖尿病且社交时差>1小时,计划样本量60例。
- 干预包括晨间5000 lx强光治疗30分钟、晚间强光减弱及睡眠提前指导,持续3周。
- 主要结局为12周时HbA1c,采用意向性分析比较干预组与对照组。
核心结论
- 社交时差可能导致2型糖尿病患者血糖和代谢控制较差,本试验旨在通过减轻社交时差来改善血糖和代谢控制,从而可能提供一种改善整体人群健康和减轻2型糖尿病疾病负担的方法。
研究设计与样本
- 随机对照试验,计划招募60例存在>1小时社交时差的糖尿病前期或2型糖尿病患者,干预组接受为期3周的晨间强光治疗(5000 lx,30分钟)、晚间强光减弱及睡眠提前指导,对照组维持常规睡眠习惯,主要结局为12周时HbA1c,采用意向性分析。
关键数值与推荐
- 主要结局为12周时糖化血红蛋白(HbA1c),比较干预组与对照组,采用意向性分析。
- 次要结局在3周和12周评估,包括社交时差、胰岛素敏感性、空腹血糖、降糖药物使用、感知低血糖频率、代谢指标(BMI、腰围、体脂百分比、血压)、情绪(抑郁、疲劳、焦虑)、生活质量(EQ5D问卷)。
- 还将评估可能的 mediators,包括(副)交感神经系统活动(ECG和电化学皮肤电导测试)、睡眠质量和睡眠相位分布(ZMax睡眠测量头带)、唾液Dim Light Melatonin Onset(亚组)、饱腹感(10-cm VAS)、饮食(食物频率问卷)、体力活动(ActiGraph加速度计)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Social jetlag is a chronic disruption of sleep timing that is characterized by different sleep timing during workdays and free days. Social jetlag has been associated with disturbed glucose metabolism, insulin resistance, and increased risk of metabolic syndrome and type 2 diabetes. In this study, we aim to investigate whether a combination of bright light therapy in the morning, bright light reduction in the evening and sleep advance instructions for 3 weeks reduces social jetlag and if this results in improvement of glycemic and metabolic control, sleep, mood and quality of life after 3 and 12 weeks in people with prediabetes and type 2 diabetes and to assess possible mediators, compared to regular sleep habits. METHODS: In this randomized controlled trial, 60 people with prediabetes or type 2 diabetes with > 1 h social jetlag will be recruited. The intervention consists of bright light therapy (5000 lx) emitted by Vitamine-L (Lumie, UK) for 30 min each morning, combined with the advice to follow sleep advance instructions and to wear bright light-dimming goggles every evening for a period of 3 weeks. The control group adheres to their regular sleep habits and conditions. The primary outcome is glycated hemoglobin (HbA1c) after 12 weeks comparing the intervention and control in an intention-to-treat analysis. Secondary outcomes at 3 and 12 weeks are (1) social jetlag; (2) insulin sensitivity, fasting blood glucose, glucose-lowering medication use, and frequency of perceived hypoglycemia; (3) metabolic outcomes, including body mass index (BMI), waist circumference, body fat percentage, and blood pressure; (4) mood, including depression, fatigue and anxiety (measured with questionnaires); and (5) quality of life measured using EQ5D questionnaire. To assess other factors that might play a role as possible mediators, we will measure (para)sympathetic nervous system activity assessed with ECGs and electrochemical skin conductance tests, sleep quality and sleep phase distribution assessed with a sleep measuring headband (ZMax), the Dim Light Melatonin Onset in saliva samples (in a subgroup) at 3 and 12 weeks, the feeling of satiety and satiation with a 10-cm visual analog scale (VAS), diet using a food frequency questionnaire, and physical activity using an accelerometer (ActiGraph). DISCUSSION: Social jetlag can contribute to poorer glycemic control and metabolic control in those with type 2 diabetes. With this intervention, we aim to reduce social jetlag and thereby improve glycemic and metabolic control. This could offer a way to improve overall population health and to reduce the disease burden of type 2 diabetes. TRIAL REGISTRATION: ISRCTN registry ISRCTN11967109 . Registered on 9 May 2024.
引用
- Bouman EJ, Slebe R, Stenvers DJ, et al. A randomized controlled trial to assess if changing sleep timing can improve glucose metabolism in people with prediabetes and type 2 diabetes. Trials. 2024. PMID: 38997765. doi:10.1186/s13063-024-08329-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。